Our Website Uses Cookies
We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.
For more information, please contact us or consult our Privacy Notice.
Your binder contains too many pages, the maximum is 40.
We are unable to add this page to your binder, please try again later.
This page has been added to your binder.
Alexander Clarke’s practice focuses primarily on debt finance transactions. Mr. Clarke has broad experience of matters relating to debt finance and lending arrangements, including cross-border syndicated loans for investment grade borrowers and other clients, project finance, acquisition finance, venture debt finance, security arrangements and general intra-group and inter-group loan agreements. Mr. Clarke also has experience advising in relation to mergers and acquisitions and general corporate and commercial transactions.
Mr. Clarke has advised a number of individual clients in relation to various lending transactions.
Mr. Clarke has gained particular experience working with UK and international clients in the financial, life sciences, consumer goods, energy, and technology sectors.
- Advising Bacardi Limited in relation to the bank finance aspects of its acquisition of Patrón Spirits International AG and its PATRÓN® brand, the world’s top-selling ultra-premium tequila, from John Paul DeJoria, a founder of Patrón. The acquisition reflected an enterprise value for Patrón of U.S. $5.1 billion.
- Advising Bacardi Limited in relation to the negotiation and implementation of a global working capital syndicated multicurrency loan facility, to be available from 2015 onwards.
- Advising Qualcomm Inc. in relation to the sale of part of its L-Band spectrum in the UK.
- Representing Giorgio Armani S.p.A. in relation to various corporate transactions.
- Advising Magticom, Georgia’s leading telecoms company, in connection with a $100 million loan from The European Bank for Reconstruction and Development. The financing will enable MagtiCom to acquire the fixed-line broadband internet network platform from Caucasus Online in order to further expand into regions outside of Tbilisi.
- Advising Consort Medical plc, on its £160m revolving credit facility to be used in connection with its £230 million acquisition of Aesica Holdco Limited from Silverfleet Capital and its management.
- Advising Oxford BioMedica plc, a Main Market listed gene based biopharmaceutical company, on the security aspects of its $50 million secured loan facility from a subsidiary of Oberland Capital Healthcare.
- Advising ICICI Bank Limited and Standard Chartered Bank on matters relating to an aggregate of US$925m in project financing.
- Advising Bacardi Limited in relation to the negotiation and implementation of various working capital and acquisition finance multicurrency loan facilities from 2008 to the present.
- Advising Axis Bank Limited, an Indian private bank, as lead arranger for an aggregate of US$180m in project financings supporting two separate projects being undertaken by Reliance Pharmaceuticals Private Limited.
- Advising a private equity fund in relation to a €45,000,000 credit facility.
- Representing a national oil company in relation to the provision of a $300m loan to a UK entity.
- Advising in relation to on-going covenant compliance by a project company in relation to a major project finance transaction.
- Advising Solar Century Holdings Limited in respect of general corporate matters.
- Representing a private investor in relation to the financing of Wandering Star Pictures Limited, to assist in the production and distribution of the movie "Solomon Kane."
- Advising various life sciences and technology companies in relation to venture debt loans and bi-lateral lending facilities.
Pro Bono
- Advising a charity that provides advice and support to victims of domestic violence in relation to its secured financing arrangements.
- Providing general corporate advice to a UK-based charity that develops economic models and analytical tools to assess international development interventions.
- Data protection advice in relation to an individual who was the victim of identity theft.
Covington's London Public Company Practice Closes a Strong Year of Life Sciences Transactions
January 25, 2021
LONDON–Covington’s London corporate team has advised AIM- and Main Market-listed clients on multiple fundraisings and acquisitions over the past few months, marking a strong year in life sciences transactions. These include: Advising Sensyne Health plc, a UK clinical AI company listed on the London AIM market, on its £27.5 million equity fundraising The ...
Covington Represents Alion Science and Technology in $225 Million Sale of its Naval Systems Business Unit
May 23, 2019
WASHINGTON—Covington is representing Alion Science and Technology Corporation in a recently announced deal to sell its Naval Systems Business Unit to Serco Inc. for $225 million. The sale, subject to certain regulatory approvals, is expected to close in the second half of 2019. Headquartered in McLean, VA, Alion delivers advanced engineering, IT and, operational ...
January 22, 2018
WASHINGTON—Covington advised Bacardi Limited in its definitive agreement to acquire Patrón Spirits International AG and its PATRÓN® brand, the world’s top-selling ultra-premium tequila, from John Paul DeJoria, a founder of Patrón. The transaction reflects an enterprise value for Patrón of $5.1 billion. The transaction follows the successful relationship the ...
Covington Announces New Counsel
April 1, 2016
WASHINGTON, DC — Covington has promoted eight lawyers to of counsel and eight to special counsel, effective April 1, 2016. The new of counsel are as follows: Stefanie Doebler (Washington) focuses her practice on health care compliance matters for pharmaceutical and medical device clients. She provides advice related to advertising and promotion, fraud and abuse, ...
Covington Advises Consort Medical on Aesica Holdco Acquisition and related £260 million financing
October 10, 2014
LONDON, 10 October, 2014 — Covington & Burling is advising Consort Medical plc on the acquisition of Aesica Holdco Limited and its operating subsidiaries from private equity fund Silverfleet Capital and its management shareholders for a total consideration of approximately £230 million. Covington is also advising Consort Medical plc on the £98.9 million Rights ...
10/21/2011
LONDON, 21 October, 2011 — Covington & Burling LLP is advising Axis-Shield plc on the recommended £235 million all cash public takeover offer from Alere, Inc., a US company listed on the New York Stock Exchange. Axis-Shield is a Scottish-Norwegian company, listed on the London and Oslo Stock Exchanges, that develops and manufactures in vitro diagnostic tests for ...
Covington Advises Energy Conversion Devices on Acquisition of Solar Integrated Technologies
7/22/2009
WASHINGTON, DC, July 22, 2009 — Energy Conversion Devices, Inc. (ECD), a NASDAQ-listed leading global manufacturer of thin-film flexible solar laminate products for the building integrated and commercial rooftop markets, and Solar Integrated Technologies, Inc. (SIT), an AIM-listed leading provider of building integrated photovoltaic roofing systems, today ...
8/19/2008
LONDON, August 19, 2008 — International Specialty Products, Inc. (ISP) has completed its previously announced sale of its hydrocolloids ingredients business to FMC Corporation. The London office of Covington & Burling LLP advised ISP on the transaction. ISP is a leading global supplier of specialty chemicals and performance-enhancing products for a wide variety ...